), NK-Zellen, B-Zellen, IL1β, IL6, IL10 und Oxytocin, wurden in beiden Gruppen longitudinal analysiert (n = 2 × 26). Unter Zuhilfenahme von 3 verschiedenen Instrumenten wurde eine Reihe von QoL-Parametern analysiert. Die statistische Auswertung war so angelegt, dass jeder Patient als seine eigene Kontrolle diente. Ergebnisse: Die Häufigkeit von zytotoxischen CD8 + -T-Zellen (prozentualer Anteil an Lymphozyten analysiert mittels Durchflusszytometrie) nahm in der anthroposophischen gegenüber der konventionell behandelten Gruppe im Zeitverlauf signifikant ab (wiederholte ANOVA-Messungen; p = 0,05). Während für weitere immunologische Parameter keine größeren Unterschiede festgestellt wurden, verbesserten sich die QoL-Variablen; die Angst verringerte sich und die physischen Symptome verbesserten sich signifikant in der anthroposophischen Gruppe (p = 0,04 bzw. p = 0,05). Schlussfolgerung: Insgesamt zeigte sich, dass es während des untersuchten Zeitraums keinen Unterschied in den Immunprofilen von Brustkrebspatientinnen mit anthroposophischer gegenüber solchen mit ausschließlich konventioneller Therapie gab. Die Verbesserung der physischen Symptome sowie die verringerte Angst in dieser Gruppe könnte die Gehirnimmunachse beeinflusst und zu einer geringeren Häufigkeit der CD8 + -T-Zellen, einem Kennzeichen für weniger aggressive Tumorstadien, geführt haben. Um beurteilen zu können, ob diese Beobachtung mit einer guten oder schlechten Prognose assoziiert ist, sind weitere detaillierte Untersuchungen von Gedächtnis-und naiven CD8 + -T-Zellen am Tumorort und in der Blutzirkulation unerlässlich.
Introduction
Breast cancer is the second most common cancer in the world after lung cancer, and, by far, the most frequent cancer among women with an estimated 1.67 million new cancer cases diagnosed in 2012 (25% of all cancers) [1] . Aspects of quality-of-life (QoL) and overall life situation for women with breast cancer and their families has developed into an important area of research [2] . Many patients with cancer and other serious diseases often choose complementary medicine including anthroposophic medicine. The principles underlying anthroposophy were developed by Rudolf Steiner and Ita Wegman . The word is derived from Greek, anthropos (human) and sophia (wisdom). The idea is to develop spiritual wisdom through human self-knowledge [3, 4] . In anthroposophic medicine, natural scientific methods used in conventional medicine are not contraindicated. The effectiveness of anthroposophic therapies are important to evaluate also from a patient's preference point of view. As a step towards better evaluation of these therapies practiced in Sweden, we performed several QoL studies on women with breast cancer, who received anthroposophical care (A group) in addition to conventional care and compared these with patients receiving conventional care only (C group) [5] [6] [7] [8] . Three instruments were used for evaluation of perceived QoL: (1) Life Satisfaction Questionnaire (LSQ) [6, 9, 10] , (2) 
the European Organization for Research and Treatment of
Cancer (EORTC) Quality-of-Life Questionnaire (QLQ)-C30, and (3) a coping scale named Mental Adjustment of Cancer (MAC scale) [11] . It was previously shown that women receiving anthroposophic medicine increased their perceived QoL over a period of 1 year [7] . A 5-year follow-up study on the same cohort of women (n = 60 + 60) showed that the mortality rates did not differ significantly in the 2 groups (11 died in the A group during the first year and 9 in the C group), and the first year increase in QoL found in the A group was not retained at 5 years [8] . QoL parameters during the first 6 months have not been presented previously.
Psychological and physiological stressors such as cancer, acute hypoglycemia, starvation, shift work, cardiac infarction, trauma, and pain affect the immune system via multiple neuroendocrine mediators (brain-immune axis) [12] . Conversely, alterations in the immune system, such as infections and inflammatory conditions, might have strong effects on brain and behavior (sleep pattern, fatigue, libido, social withdrawal, etc.) via cytokines and neuropeptides, released by immune cells and binding to hypothalamic cytokine receptors [13] . Salutary interventions that influence and dampen the hypothalamus-pituitary-adrenal (HPA) axis include good nursing care, social support, and social interactions. Women with breast cancer frequently show compromised immune functions with elevated immunological activation and proinflammatory cytokines release [14] . A history of childhood maltreatment has been found associated with increased profiles of proinflammatory signaling [15] , as well as cancer-related psychological distress [16] .
Social support in breast cancer survivors is linked to lower inflammation and reduced amygdala reactivity (threat related brain regions) [14] . Oxytocin is a neuropeptide with psychosocial and psychophysiological functions, and a mediator of antistress, wellbeing, social interaction [17] . Immunological and genetic surveillance of several types of cancers including breast cancer have been reported [18] .
The aim of this study was to evaluate immune and QoL parameters in women receiving conventional with or without integrated anthroposophic care to detect possible differences in these parameters within the first 6 months after admission. The immune parameters were selected to reflect possible stress-related alterations in the distribution of lymphocyte subsets, as well as inflammatory and anti-inflammatory conditions.
Patients and Methods

Study Design and Patients
The subjects were women with breast cancer who themselves chose the anthroposophic hospital for treatment. In the previously reported main study, 60 women who met the inclusion criteria, i.e., 75 years old or younger, residing in Stockholm, Sweden, able to communicate in Swedish, and expected to live and stay in Sweden for at least 6 months, were enrolled in the study from November 1995 to January 1999. Each woman received conventional medical cancer treatment in addition to anthroposophic care, and was individually matched with a woman (from an oncology out-patient department in the southern Stockholm area) who received conventional treatment only, as previously described [7] . All women in the A group had anthroposophic care in addition to conventional care. The first 26 consecutive women from each group (n = 60) that entered the study were selected for immunological analysis; thus, the present study consists of 26 women in the A group and 26 women in the C group. The mean age in the A group was 49.2 years (range 28-69 years) and the mean age in the C group was 49.9 years (range 36-68 years). The groups were similar also with regards to staging of breast cancer, and the proportion of women that had received cytostatic drugs, irradiation therapy, or no treatment ( table 1 ) within the last 3 months. Neither age, staging nor treatment differed significantly between the groups (t-test and Chi-square test > 0.1).
Ethical Approval
All procedures involving human participants were approved after ethical investigation by the Regional Research Ethics Committee at the Karolinska Institute, Stockholm, Sweden: Dnr 95-293 and Dnr 01-015, E. Hamrin, in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards [19] . Informed consent was obtained from all individual participants included in the study.
Quality-of-Life Instruments
Three different instruments to evaluate QoL variables were used in this study. (1) The mini-MAC is a revised version of the widely-used MAC scale, developed for measuring mental adjustment to cancer in a general cancer population [11] . The 5 parameters are: (a) helpless-hopeless, e.g., 'I feel completely at a loss about what to do' (8 items); (b) cognitive avoidance, e.g., 'I distract myself when thoughts about my illness come into my head' (4 items); (c) fighting spirit, e.g., 'I try to fight the illness' (4 items); (d) anxious preoccupation, e.g., 'I worry about the cancer returning or getting worse' (8 items); (f) fatalism, e.g., 'I've had a good life; what's left is a bonus' (5 items). (2) LSQ consists of 34 items on 7-point scales [9] . The 34 items are allocated to 6 different factors as follows: physical symptoms (PS), sickness impact (SI), quality of daily activities (QDA), socioeconomic situation (SES), quality of family relation (QFA), and quality of close friend relationship (QFR). (3) EORTC Study Group on Quality of Life has developed a modular measurement system for evaluating quality of life in cancer patients [20] . This consists of 30 items expressed in 6 functional scales and 9 symptom scales. In order to avoid redundancy with the other scales and to reduce the number of parameters in the significance testing, we decided to use only the 'QL' (global quality of life) parameter from the EORTC scale.
Interventions
Both groups had been treated according to a special regional care program for all patients belonging to the Stockholm/Gotland region. The women who chose anthroposophic care were additionally treated with a special care program during their stay at the anthroposophic hospital (mean value 14 days, range 5-29 days). The individually-composed anthroposophic therapies consisted of holistic care including natural products, Iscador (a cancer adjuvant medicament consisting of mistletoe extract), diets, art therapy, rhythmic therapy, therapeutic massage, and hydrotherapy as previously described [8] . Most of the patients in the A group continued to use Iscador after the first 2 weeks following their visit to the anthroposophic hospital.
Procedure
In the previously-reported main study, the women were followed for 5 years and were assessed by the questionnaires on 6 occasions as follows: on admission, after 1 month, after 3 months, after 6 months, after 1 year, and after 5 years [8] . In the immunological study, we used the questionnaire assessments on admission, after 3 months, and after 6 months, which corresponds to the time points when the blood samples were obtained for measurements of immunological parameters.
Medical Investigations
These included laboratory tests, x-ray, scintigraphy, ultrasound of liver, etc., but no differences between the groups were found.
Immunological Analysis
An immunological test package including 14 variables was performed at admission, after 3, and 6 months, at the same time points when questionnaires (see table 1 ). In addition, levels of cytokines IL1β, IL6 (pro-inflammatory) and IL10 (anti-inflammatory) were analyzed in batch by multiple bead array (Milliplex MAP human cytokine panel from Millipore, Billerica, MA, USA), according to the manufacturer's instructions using frozen sera stored at -70 ° C. The lowest detection level was 3.2, 0.13, and 0.32 pg/ml, respectively. The neuropeptide oxytocin was analyzed by an enzyme-linked immunosorbent assay (Correlate-EIA oxytocin kit, Assay Designs, Ann Arbor, MI, USA), according to the manufacturer's instructions. The lowest detection level was 4.7 pg/ml.
Statistical Analysis
The main point was to analyze whether A and C groups differed over time. A strict procedure, in order to avoid mass significance due to multiple testing, was therefore applied involving analysis of variance (ANOVA) for repeated measures (adjusted for sample size and age) to identify any significant differences between the 2 groups over time (0, 3, and 6 months). Only when a significant difference between the groups was found (p ≤ 0.05), we subsequently used t-test to investigate any differences between the groups at each time point. These p values were derived from one-sided testing, since it was at this point already noted which group had the higher mean value. 
Results
Immunological Differences between Anthroposophic and Conventional Care Groups
We found a significant decrease over time in the proportion of cytotoxic CD8 + T cells in the anthroposophic group compared with the conventional care group (p = 0.05 by repeated measures ANOVA, corrected for age) ( fig. 1 ) . At admission (time point '0') there was no difference in the cytotoxic T-cell fraction between the groups (t-test, p = 0.9), while the decrease over time in the anthroposophic group led to a significantly lower proportion at 6 months (t-test, p = 0.01 between-group comparison at 1 time point). Among the other immunological variables, including serum levels of IL1β, IL6, IL10, or oxytocin, we found no significant differences between the groups over the time course ( table 2 ) .
Quality-of-Life Differences between Anthroposophic and Conventional Care Groups
Regarding QoL measurements, the A group showed a high level of anxiety (a MAC scale item) at inclusion (p = 0.01, betweengroup comparison at 1 time point compared with the C group, fig. 2 ) . However, the level decreased over time, which was in contrast to the C group that had a low anxiety level at inclusion and remained low over time (repeated measures ANOVA, p = 0.04 for comparison between groups over time). There was also a difference over time (repeated measures ANOVA, p = 0.05) for physical symptoms (PS), 1 of the items in the life satisfaction questionnaire. The A group started at a low level (= many physical symptoms = 'bad condition'), p = 0.007 (t-test at time point 0) compared with the C group ( fig. 3 ) but increased (i.e . , less physical symptoms) to 3 months and then remained the same, while the C group had a high level at all points. Among the other variables, no significant differences over time were noted between the groups ( table 3 ). 
Discussion
The present study on women with breast cancer, who were treated with 2 different regimens, included the first 6 months after admission to conventional with or without anthroposophic care and focused on immunological and QoL profiles and compared the patients in the 2 groups. Anthroposophic medicine today is used frequently especially in many European countries [4] and several studies indicate both preclinical and clinical effects of cancer breast therapy adjuvants such as Iscadore, a mistletoe extract [21] . However, evidenced-based complementary medicine studies are scarce.
The major and most important finding of this study is that the proportion of cytotoxic CD8 + T cells decreased in A-group patients over the 6-month period, which was not found in the C group. What is the function of CD8 + cells in breast cancer and what does the change in CD8 + cells imply? As a background, CD8 + T cells participate in the defense against viruses and certain cancers. Most tumor cells express antigens that can mediate an apparently specific and functional immune response including recognition by host CD8 + T cells. However, most tumors that are detected clinically must have evaded antitumor immune responses to grow progressively, pointing at a strong tolerance inducing conditions [22] . Recent therapies are, therefore, focused on breaking this tolerance using therapeutic monoclonal antibodies against molecules (called check-points of immunity) that decide activation versus tolerance of immune responses, for example PD-1, PD-L1, or CTLA-4 [23] . Humanized antibodies against these targets are used for treatment of several tumor types and are now evaluated in clinical trials including breast cancer [24] . In breast cancer, significantly higher blood CD8 + T cell frequencies, both total CD8 + cells and especially memory CD8 + cells, were observed in patients with metastatic (more aggressive) versus nonmetastatic (less aggressive) disease [25] . The authors observed an increase in CD8 + frequencies both in the tumor microenvironment, and in the circulation [25] . Based on these observations, we suggest the following interpretation of findings in the present study: The statistically significant reduction of CD8 + cells over time (repeated measures ANOVA) found in the A group, but not in the C group, may indicate that complementary treatment generates a less aggressive disease, at least during the observation time of 6 months. Of the 21 women in the A group, the 16 who took part in the 5-year follow up had continued the contact with the anthroposophic hospital in different ways, but it is unknown as to what extent [8] . However, in a 5-year follow-up study, there was no difference in mortality between the 2 groups [8] . An important aspect of further studies is to characterize the different CD8 + subtypes such as naïve and memory CD8 + T cells and their differentiation state, particularly in view of the fact that tumor cells potentially induce immunosenescence reminiscent of cytomegalovirus-induced immunosenescence [25] .
The anthroposophic A group showed a high level of anxiety when included in the study in contrast to the C group. This fact points at some limitations of the study, which must be considered. First, a randomized clinical study would have been preferable, but it was not possible considering the resources available and the regulations of the Swedish health care system. Thus, the present design with individually matched pairs was an option. But since the women took initiatives themselves to be referred to anthroposophic care, there could be differences between the women in A group and the women in the C group that were not controlled for by the matching procedure. The women were individually matched regarding stage of disease, age, treatment during the 3 months before entering the study and prognosis. There were no differences between the groups regarding children or marital status, but there was a difference regarding the professions of the women on admission to the study [26] . In the A group 23% compared with none in the C group were working as artists, journalists, or other cultural workers. This could be one explanation to why some of the women choose the anthroposophic hospital, and it could also mean that the 2 groups differed psychologically, i.e., the anxiety level differed at admission. Noteworthy, personality traits (extraversion vs. in- [27] . It is also known that stress-release programs, ethical caring, choir singing, and psychotherapy have beneficial effects on women with breast cancer [28] [29] [30] [31] , and an important stress-reducing aspect of anthroposophic care is the individually composed therapy consisting of holistic care including natural products, Iscador, diets, art therapy, rhythmic therapy, therapeutic massage, and hydrotherapy [3, 4] . A deeper psychoneuroimmunological understanding of these effects induced by intervention programs are needed [32] .
Fourteen immunological parameters were longitudinally investigated in the present study. In the evaluation process over time, from time of admittance, to 3 months, and finally at 6 months, it is important to recognize that each patient served as her own control, which is a strength of this study. There is a large interindividual variation in immune parameters such as lymphocyte populations. However, the intraindividual variation over time is limited; hence, the interindividual variation is overcome by the design of the study [33] . A potential limitation was that several immunological and QoL parameters were investigated. However, the issue of masssignificance was overcome by using a strict and stringent statistical approach taking the multiparameter design into account.
In conclusion, the present results indicate that complementary therapy did not differ significantly in their immune profiles over time compared with conventional therapy, with 1 significant exception of decreased cytotoxic CD8 + T cells in the A group. Significantly improved physical symptoms and less anxiety over time in this group may have influenced this reduced frequency of CD8 + T cells, a feature reported to be associated with less aggressive cancer stages. This finding is a basis for further studies on memory and naïve CD8 + T function in breast cancer and their relation to a good or bad prognosis, particularly in view of recent findings that CD8 + memory cytotoxic T cells have shorter telomere lengths and are associated with stress-related hormones and lifestyle changes [34, 35] .
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